19-29529967-T-C

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_001146339.2(VSTM2B):​c.446T>C​(p.Leu149Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000314 in 1,547,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00018 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00033 ( 0 hom. )

Consequence

VSTM2B
NM_001146339.2 missense

Scores

1
4
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.44

Publications

0 publications found
Variant links:
Genes affected
VSTM2B (HGNC:33595): (V-set and transmembrane domain containing 2B) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14530042).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VSTM2BNM_001146339.2 linkc.446T>C p.Leu149Pro missense_variant Exon 4 of 5 ENST00000335523.8 NP_001139811.1 A6NLU5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VSTM2BENST00000335523.8 linkc.446T>C p.Leu149Pro missense_variant Exon 4 of 5 5 NM_001146339.2 ENSP00000335038.6 A6NLU5

Frequencies

GnomAD3 genomes
AF:
0.000177
AC:
27
AN:
152208
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000123
AC:
18
AN:
146104
AF XY:
0.000140
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000409
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000290
Gnomad OTH exome
AF:
0.000236
GnomAD4 exome
AF:
0.000329
AC:
459
AN:
1394866
Hom.:
0
Cov.:
32
AF XY:
0.000342
AC XY:
235
AN XY:
688086
show subpopulations
African (AFR)
AF:
0.0000317
AC:
1
AN:
31564
American (AMR)
AF:
0.0000280
AC:
1
AN:
35658
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25146
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35704
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79156
European-Finnish (FIN)
AF:
0.0000220
AC:
1
AN:
45522
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5660
European-Non Finnish (NFE)
AF:
0.000415
AC:
448
AN:
1078532
Other (OTH)
AF:
0.000138
AC:
8
AN:
57924
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
37
73
110
146
183
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000177
AC:
27
AN:
152208
Hom.:
0
Cov.:
33
AF XY:
0.000188
AC XY:
14
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.0000724
AC:
3
AN:
41438
American (AMR)
AF:
0.00
AC:
0
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000361
Hom.:
0
Bravo
AF:
0.000193

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 14, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.446T>C (p.L149P) alteration is located in exon 4 (coding exon 4) of the VSTM2B gene. This alteration results from a T to C substitution at nucleotide position 446, causing the leucine (L) at amino acid position 149 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.49
CADD
Pathogenic
28
DANN
Uncertain
1.0
DEOGEN2
Benign
0.016
T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.028
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Benign
0.64
T
M_CAP
Benign
0.027
D
MetaRNN
Benign
0.15
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
3.4
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.052
Sift
Benign
0.21
T
Sift4G
Benign
0.28
T
Polyphen
0.16
B
Vest4
0.49
MVP
0.15
ClinPred
0.15
T
GERP RS
4.3
Varity_R
0.63
gMVP
0.79
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs973209969; hg19: chr19-30020874; API